Interim report January 1 - September 30, 2017
RaySearch Laboratories AB (publ)“In the first nine months of the year, net sales rose 12 percent to SEK 380 M (340). The operating margin declined to 16 percent (29) due to lower growth for RayStation®, negative currency effects due to the weakening of the USD and higher costs due to the company’s investments in the global marketing organization and in research and development. The development of RayCare® is continuing as planned,” says Johan Löf, President and CEO of RaySearch. THIRD QUARTER (JULY-SEPTEMBER 2017) · Net sales SEK 111.7 M (125.7), of which revenues from RayStation